drugset / Trial / NCT00004763

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

NCT00004763 ↗

RandomizedTreatment

Summary

OBJECTIVES: I. Evaluate the beneficial effects of leuprolide depot, oral contraceptive therapy, and leuprolide/oral contraceptive therapy in the management of patients with ovarian hyperandrogenism.

Timeline

Start
1993-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ethinyl estradiol/norethindrone Unknown — Oral
Subject Leuprolide Other / unclassified — Intramuscular

Indications

No indication recorded.